Enfusion Correlations
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
The current 90-days correlation between Enfusion and E2open Parent Holdings is -0.01 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enfusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enfusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Enfusion Correlation With Market
Average diversification
The correlation between Enfusion and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and DJI in the same portfolio, assuming nothing else is changed.
Enfusion |
Moving against Enfusion Stock
| 0.61 | WMT | Walmart Common Stock | PairCorr |
| 0.55 | LNDNF | Lundin Energy AB | PairCorr |
| 0.55 | MCD | McDonalds | PairCorr |
| 0.43 | AA | Alcoa Corp | PairCorr |
| 0.4 | JNJ | Johnson Johnson | PairCorr |
| 0.39 | TRV | The Travelers Companies | PairCorr |
| 0.38 | MRK | Merck Company Aggressive Push | PairCorr |
| 0.35 | BAC | Bank of America | PairCorr |
| 0.35 | XOM | Exxon Mobil Corp | PairCorr |
| 0.34 | VZ | Verizon Communications | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Enfusion Stock performing well and Enfusion Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Enfusion's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ETWO | 2.00 | 0.75 | 0.31 | 3.84 | 1.06 | 4.93 | 26.87 | |||
| ML | 0.43 | 0.00 | (0.10) | 0.00 | 0.57 | 0.68 | 2.27 | |||
| VERB | 7.38 | 1.06 | 0.09 | (0.18) | 7.60 | 10.97 | 139.80 | |||
| CLBT | 2.04 | 0.16 | 0.03 | (1.11) | 2.73 | 3.42 | 25.88 | |||
| MODN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| AVPT | 1.74 | (0.27) | 0.00 | (0.12) | 0.00 | 3.04 | 18.33 | |||
| WKME | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PENG | 2.40 | (0.58) | 0.00 | (0.22) | 0.00 | 5.14 | 21.59 | |||
| MKFG | 3.24 | 0.73 | 0.13 | (0.59) | 3.98 | 9.46 | 33.63 |
Enfusion Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enfusion stock to make a market-neutral strategy. Peer analysis of Enfusion could also be used in its relative valuation, which is a method of valuing Enfusion by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Enfusion Corporate Management
| Stephen Dorton | Chief Officer | Profile | |
| Michael Berry | Chief Officer | Profile | |
| Lorelei Skillman | Chief Officer | Profile | |
| Vivek Ranka | Head Technology | Profile | |
| Stephen Malherbe | Managing Partner | Profile | |
| Oleg Movchan | Interim Director | Profile | |
| Matthew Campobasso | General Secretary | Profile |
Still Interested in Enfusion?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.